Access cutting-edge chronic rhinosinusitis treatment through this clinical trial at a research site in Orlando. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Orlando location
Access chronic rhinosinusitis specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related chronic rhinosinusitis treatment provided free
Check if you qualify for this chronic rhinosinusitis clinical trial in Orlando, FL
No-Cost Study Care
Local to Orlando
Convenient for FL residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
EFC18418 is a multinational, randomized, double-blind, placebo-controlled, parallel-group, Phase 3 study with 3 treatment groups. The purpose of the study is to evaluate the efficacy, safety and tolerability of 2 dosing regimens of itepekimab compared to placebo as add-on therapy to intranasal corticosteroids (INCS) in male and female participants with chronic rhinosinusitis with nasal polyps (CRSwNP) aged 18 years of age and older. Study details include: * The study duration per participant (
Sponsor: Sanofi
Yes, this clinical trial (NCT06834347) has an active research site in Orlando, FL that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for chronic rhinosinusitis treatment options in Orlando, FL, this clinical trial (NCT06834347) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Orlando research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic rhinosinusitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all chronic rhinosinusitis clinical trials near you to find additional studies recruiting in your area.
See all interstitial cystitis clinical trials recruiting in Orlando — not just this study.
Browse Interstitial Cystitis Trials in Orlando →